• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-08-04

  Wang et al. (2018) systematically demonstrated that genotype III grass carp reovirus (GCRV104) enters host cells primarily via clathrin-mediated, pH-dependent endocytosis, rather than through actin cytoskeleton disruption. This mechanistic clarity informs future virology studies and guides the selective deployment of cytoskeletal inhibitors such as Latrunculin B in cellular entry research.

• CHK1 Inhibition in Breast Cancer: Impact of ER/PR Status on

  2026-08-04

  This article analyzes how the therapeutic response to CHK1 inhibition in breast cancer is determined by the estrogen and progesterone receptor (ER/PR) status. The study demonstrates that CHK1 inhibition enhances chemotherapy sensitivity in ER−/PR−/HER2− subtypes but acts as a single-agent antitumor agent in ER+/PR+/HER2− cancers, informing precise application strategies for molecular targeted therapy.

• DIDS: Mechanistic Insights and Translational Precision in Io

  2026-08-03

  Explore the advanced mechanisms of DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) as a chloride channel inhibitor with unique roles in tumor biology and neuroprotection. This article delivers a deeper mechanistic and translational analysis, highlighting new scientific evidence and practical assay considerations.

• Tomivosertib Inhibits Ectopic Activity in Human DRG Neurons

  2026-08-03

  This study provides the first direct evidence that MNK inhibition via tomivosertib reversibly suppresses spontaneous activity in human dorsal root ganglion neurons from radiculopathy patients. The findings highlight a promising therapeutic approach for neuropathic pain and establish a robust experimental workflow for translational neuropharmacology research.

• Pregnenolone Carbonitrile: Neuroendocrine Modulation & Hepat

  2026-08-02

  Explore the multifaceted roles of Pregnenolone Carbonitrile in neuroendocrine modulation and hepatic detoxification. This article uncovers novel glucocorticoid receptor-mediated mechanisms, distinguishing PCN's applications from conventional PXR-focused research.

• FAST Platform: Food-Grade Nanoparticles for Bioactive Delive

  2026-08-01

  The referenced study introduces Facilitated Self-Assembling Technology (FAST) as a breakthrough, surfactant-free method for preparing stable, food-grade nutraceutical nanoparticles. This clean-label approach enables efficient delivery of hydrophobic bioactives, with strong implications for next-generation oral supplements and functional foods.

• PreScission Protease (PSP): Workflow Guide for Precise Tag C

  2026-07-31

  PreScission Protease (PSP) provides precise, site-specific cleavage of fusion protein tags, streamlining recovery of native proteins in purification workflows. PSP is best suited for low-temperature protocols requiring HRV 3C protease specificity and is not intended for cleavage of non-cognate sequences or applications outside molecular biology. Careful attention to buffer composition and storage conditions ensures optimal enzyme performance.

• 5-Aminolevulinic acid HCl: Optimizing Heme Biosynthesis Assa

  2026-07-31

  Leverage 5-Aminolevulinic acid HCl for high-fidelity heme biosynthesis and immune evasion research. Discover advanced protocols, troubleshooting strategies, and translational insights informed by the latest Salmonella infection models.

• Biohybrid Euglena Microrobots: Multimodal Tumor Targeting In

  2026-07-30

  This article examines the development of magnetically guided biohybrid microrobots built on Euglena gracilis, providing adaptive, multimodal locomotion for effective tumor barrier penetration. The study's findings offer new strategies for non-invasive, multifunctional tumor therapy by integrating biological flexibility with controlled magnetic navigation.

• Biohybrid Euglena Microrobots for Tumor Targeting and Barrie

  2026-07-30

  The referenced study introduces magnetically guided biohybrid microrobots based on Euglena gracilis, capable of adaptive, multimodal locomotion and barrier penetration for tumor therapy. This innovation enables precise tumor targeting and multifunctional treatment in challenging biological environments, offering a new paradigm for microrobotic precision medicine.

• Lysozyme–Amikacin Complexes: Mechanistic Insights via Spectr

  2026-07-29

  This study elucidates how amikacin, a semisynthetic aminoglycoside antibiotic, binds to lysozyme, preserving its structure but abolishing enzymatic activity. By integrating tritium probe labeling, fluorescence spectroscopy, and molecular docking, the research advances our understanding of antibiotic mechanism of action and informs future studies of protein–antibiotic interactions.

• PINK1/Park2-Mediated Mitophagy Alleviates NAFLD Pathology

  2026-07-29

  This study demonstrates that enhancing Park2-mediated mitophagy reverses mitochondrial and lipid metabolic dysfunction in a non-alcoholic fatty liver disease (NAFLD) cell model. By manipulating Park2 expression, the authors uncover mechanistic links between mitophagy, inflammation, and hepatic lipid accumulation, suggesting new therapeutic avenues for NAFLD.

• Semi-Automated Screening of Fast-Dissociating V5 Tag Antibod

  2026-07-28

  Miyoshi et al. developed a semi-automated single-molecule microscopy platform to identify fast-dissociating, highly specific monoclonal antibodies against epitope tags like V5. Their approach enables direct screening from hybridoma cultures, advancing multiplex imaging and revealing new insights into protein dynamics.

• Asunaprevir (BMS-650032): Molecular Insights and Next-Gen HC

  2026-07-28

  Explore how Asunaprevir (BMS-650032) redefines hepatitis C research by offering unique insights into NS3 protease inhibition and advanced assay design. This article delivers a molecular deep dive and highlights recent cross-disciplinary findings.

• InstaBlue Protein Stain Solution: Rapid Coomassie Gel Staini

  2026-07-27

  InstaBlue Protein Stain Solution enables rapid, sensitive visualization of proteins in polyacrylamide gels, eliminating the need for fixation, washing, or toxic solvents. This Coomassie Brilliant Blue formulation is ideal for workflows requiring mass spectrometry compatibility and high-throughput analysis. It should not be used where traditional methanol/acetic acid staining or long-term gel archiving is required.

15668 records 1/1045 page Next 12345 下5页 Last page